MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-02-0038693
Medopharm Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹229.32 Cr
▼ 9% YoY
Net profit · FY 2025
₹97.18 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹10.41 Cr
EBITDA margin 4.5%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹22 Cr
Issued & subscribed
Open charges
₹416.26 Cr
Satisfied ₹31.02 Cr
Company age
46 yrs
Est. 1980
Employees · EPFO
462
Provident fund records
About Medopharm Private Limited
Data last updated:
Medopharm Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 March 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U15100TN1980PTC008206. Its GSTIN is 33AADCM9459R1ZM (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹22 Cr. It was formerly known as Medopharm Pharmaceuticals Private Limited. It is led by directors including Udhan Kumar Chordia (Managing Director) and Pannalal Chordia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.25 Puliyur 2nd Main Road Trustpuram, Chennai, Tamil Nadu, India – 600024.
As per the financials filed for FY 2025, the company reported a revenue of ₹229.32 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹97.18 Lakh (net margin 0.4%) and EBITDA of ₹10.41 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 2% over five years.
The company has about 462 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.
The company is associated with 1 brand: Medopharm. As per MCA filings, the company has open charges of ₹416.26 Cr and satisfied charges of ₹31.02 Cr on record. Court records list 25 cases involving the company, including 21 filed by the company and 4 filed against it; 3 cases are pending. The company has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹17 Cr; the latest was in March 2022. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Emil Pharmaceutical Industries Private Limited with revenue of ₹232.55 Cr.
Medopharm Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0038693). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medopharm.com.
Company details
CIN U15100TN1980PTC008206
Registration Number 008206
Incorporation Date 31 March 1980
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0038693
CIN history
Medopharm has one previous CIN (Corporate Identification Number): U24231TN1980PTC008206. The current CIN is U15100TN1980PTC008206, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U15100TN1980PTC008206 | Current |
| U24231TN1980PTC008206 | Previous |
Key People
Udhan Kumar Chordia Managing Director Pannalal Chordia Director Surendar Chordia Director Recognitions & Rankings of Medopharm
Contact details
Medopharm Private Limited's registered office is in Chennai, Tamil Nadu. Its website is medopharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.25 Puliyur 2nd Main Road Trustpuram, Chennai, Tamil Nadu, India – 600024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medopharm Private Limited, buy the company report.
Comprehensive company report
Medopharm Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medopharm operates one associated brand: Medopharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, export, and services in India. | medopharm.com |
Business activity
The main business activity of Medopharm is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medopharm Private Limited, buy the company report.
Financials of Medopharm Private Limited
FY 2025 filings availableMedopharm Private Limited reported revenue of ₹229.32 Cr (down 9% YoY) for FY 2025.
Revenue · FY 2025
₹229.32 Cr ▼ 9%
Net profit · FY 2025
₹97.18 Lakh margin 0.4%
EBITDA · FY 2025
₹10.41 Cr margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 10%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 3%
5 years · compounded
▼ 17%
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medopharm Private Limited, buy the company report.
Board of directors of Medopharm Private Limited
Medopharm has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pannalal Chordia | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Udhan Kumar Chordia Also directs: Zovaris Life Sciences Private Limited, Agma Health Foods and Merchandising Private Limited, Altiouss Developers LLP and 2 more | Managing Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Surendar Chordia | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Gambhir Chordia Also directs: Zovaris Life Sciences Private Limited, Medopharm Wellness Private Limited, Agma Packaging Private Limited and 3 more | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Mohanmull Ranjitmull Chordia Also directs: Agma Packaging Private Limited | Director | 14 Dec 2004 | 21 Years 10 Months | Current |
Peer comparison
Medopharm Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emil Pharmaceutical Industries Private Limited | ₹232.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ahlcon Parenterals (India) Limited | ₹229.53 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Medopharm Private Limitedthis company | ₹229.32 Cr (FY 2025) | ₹97.18 Lakh | 0.4% | -9.0% | 462 | Chennai, Tamil Nadu, India |
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India |
To see the full peer comparison of Medopharm Private Limited, buy the company report.
Auditor
Medopharm Private Limited is audited by Sthalasayanam for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sthalasayanam | FY 2024 |
Shareholding
The shareholding of Medopharm Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medopharm Private Limited, buy the company report.
Charges & borrowings
Open charges
₹416.26 Cr
Satisfied charges
₹31.02 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2024 | 101004657 | Hdfc Bank Limited | ₹21.5 Cr | Open | |
| 29 Aug 2023 | 100777168 | Yes Bank Limited | ₹1.89 Cr | Open | |
| 22 Jul 2021 | 100468337 | Others | ₹9 Lakh | Open | |
| 17 Apr 2021 | 100436711 | Hdfc Bank Limited | ₹10.05 Cr | Open | |
| 03 Nov 2015 | 100045917 | Hdfc Bank Limited | ₹37.95 Cr | Open |
To see the full charge records of Medopharm Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Medopharm Private Limited has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹17 Cr; the latest was in March 2022.
Total deals
9
Funding rounds
5
Secondary share transfers
4
Disclosed funding
₹17 Cr
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Ranjitmal Chordia & Sons HUF, an individual |
| Jul 2019 | Funding round | ₹4.5 Cr | Investors: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Sampathmal Chordia & Sons HUF, an individual |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Ranjitmal Chordia & Sons HUF, Sampathmal Chordia & Sons HUF, an individual Seller: an individual |
To see the full deal history of Medopharm Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Medopharm Private Limited has 25 court cases on record: 21 filed by Medopharm, 4 filed against it. 3 cases are pending and 22 are disposed.
Total cases
25
Filed by the company
21
Filed against the company
4
Pending
3
Disposed
22
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 1 | 2 |
| District courts | 10 | 3 | 1 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Disposed |
| District court, Chennai, Tamil Nadu | Criminal miscellaneous application | Filed by the company against Organic Industries Pvt. Ltd. | Disposed |
| High Court, TAMIL NADU | Writ petition | Filed by the company against The Union of India and 4 others | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against The Union of India and 3 others | Pending |
| District court, Nellore, Andhra Pradesh | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Medopharm Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medopharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Medopharm has 1 subsidiary company, 1 joint venture, and 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
1
Joint ventures
1
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Medopharm Life Foundation | U85300TN2021NPL141625 |
To see the full group structure of Medopharm Private Limited, buy the company report.
Employees & EPFO
Medopharm Private Limited has a workforce of 462 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.
Employee count
462
Active EPFO establishments
1
Employee growth
4.76%
GST
Medopharm has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCM9459R1ZM | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medopharm Private Limited, buy the company report.
Recent activity
Medopharm Private Limited has 12 board changes on record since 2004: 6 appointments and 6 cessations. The latest: Chordia Mohanmull Sardarmal ceased to be Director on 09 Jun 2021.
AGM
Medopharm Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 153.78 Cr registered on 26 Nov 2008 with Charge ID 10136524 was modified on 28 May 2025.
Filing
Medopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.50 Cr with Charge ID 101004657 was registered on 30 Oct 2024.
Charges
A charge registered on 04 Feb 2015 via Charge ID 10562927 with Hdfc Bank Limited was fully satisfied on 27 Sep 2024.
Charges
A charge registered on 10 Dec 2019 via Charge ID 100313338 with Others was fully satisfied on 19 Aug 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 48.00 Cr registered on 04 Feb 2015 with Charge ID 10562853 was modified on 23 Jul 2024.
Charges
A charge with Yes Bank Limited amounted to Rs. 1.89 Cr with Charge ID 100777168 was registered on 29 Aug 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 10.05 Cr registered on 17 Apr 2021 with Charge ID 100436711 was modified on 26 Jun 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 37.95 Cr registered on 03 Nov 2015 with Charge ID 100045917 was modified on 26 Jun 2023.
Charges
A charge with Others of Rs. 96.50 Cr registered on 18 Nov 2005 with Charge ID 90289787 was modified on 31 Dec 2021.
Charges
A charge with Others amounted to Rs. 0.09 Cr with Charge ID 100468337 was registered on 22 Jul 2021.
31 earlier events are in the company report.
Frequently asked questions
Medopharm is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 March 1980 (46+ years old) and is registered under CIN U15100TN1980PTC008206.
Medopharm has 5 current directors:
- Udhan Kumar Chordia - Managing Director
- Pannalal Chordia - Director
- Surendar Chordia - Director
- Gambhir Chordia - Director
- Mohanmull Ranjitmull Chordia - Director
The latest financial statements of Medopharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medopharm is 33AADCM9459R1ZM, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Medopharm is U15100TN1980PTC008206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medopharm has 25 court cases on record: 21 filed by the company and 4 filed against it. 3 are pending. Most are in the high courts.
Medopharm was incorporated on 31 March 1980, making it 46+ years old. It is registered with the Registrar of Companies, Chennai.
Medopharm has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹17 Cr; the latest was in March 2022.
The peers of Medopharm by revenue are Emil Pharmaceutical Industries Private Limited, Axa Parenterals Limited, Dosch Pharmaceuticals Private Limited, Ahlcon Parenterals (India) Limited, Hindustan Laboratories Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chordia Mohanmull Sardarmal ceased to be Director on 09 Jun 2021. Gambhir Chordia ceased to be Additional Director on 31 Dec 2020. Pannalal Chordia ceased to be Additional Director on 31 Dec 2020. Medopharm has 12 board changes on record in total.
Yes, Medopharm is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-02-0038693).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages